{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:34:38Z","timestamp":1790415278819,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-146","type":"journal-article","created":{"date-parts":[[2014,6,9]],"date-time":"2014-06-09T19:02:24Z","timestamp":1402340544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling"],"prefix":"10.1186","volume":"13","author":[{"given":"Andrea","family":"K\u00f6hler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmm\u00fchan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybille","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Aranda-Orgill\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios I","family":"Karagiannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Achm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal-Ruth","family":"Schweiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Schweiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Klocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,9]]},"reference":[{"key":"1357_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1210\/er.2002-0032","volume":"25","author":"CA Heinlein","year":"2004","unstructured":"Heinlein CA, Chang C: Androgen receptor in prostate cancer. Endocr Rev. 2004, 25: 276-308. 10.1210\/er.2002-0032","journal-title":"Endocr Rev"},{"key":"1357_CR2","volume-title":"Cancer Facts and Figures 2010","author":"American Cancer Society","year":"2010","unstructured":"American Cancer Society: Cancer Facts and Figures 2010. 2010, Atlanta: American Cancer Society,"},{"key":"1357_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","volume":"19","author":"BS Carver","year":"2011","unstructured":"Carver BS, Chapinski C, Wongvipat J, Hieronymus H, Chen Y, Chandarlapaty S, Arora VK, Le C, Koutcher J, Scher H, Scardino PT, Rosen N, Sawyers CL: Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer. Cancer Cell. 2011, 19: 575-586. 10.1016\/j.ccr.2011.04.008","journal-title":"Cancer Cell"},{"key":"1357_CR4","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1158\/1078-0432.CCR-08-1171","volume":"15","author":"RM Attar","year":"2009","unstructured":"Attar RM, Takimoto CH, Gottardis MM: Castration-resistant prostate cancer: locking up the molecular escape routes. Clin Cancer Res. 2009, 15: 3251-3255. 10.1158\/1078-0432.CCR-08-1171","journal-title":"Clin Cancer Res"},{"key":"1357_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.beem.2009.11.002","volume":"24","author":"R Werner","year":"2010","unstructured":"Werner R, Gr\u00f6tsch H, Hiort O: 46, XY disorders of sex development\u2013the undermasculinised male with disorders of androgen action. Best Pract Res Clin Endocrinol Metab. 2010, 24: 263-277. 10.1016\/j.beem.2009.11.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1357_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/ng762","volume":"29","author":"A Trockenbacher","year":"2001","unstructured":"Trockenbacher A, Suckow V, Foerster J, Winter J, Krauss S, Ropers HH, Schneider R, Schweiger S: MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet. 2001, 29: 287-294. 10.1038\/ng762","journal-title":"Nat Genet"},{"key":"1357_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/bies.10256","volume":"25","author":"S Schweiger","year":"2003","unstructured":"Schweiger S, Schneider R: The MID1\/PP2A complex: a key to the pathogenesis of Opitz BBB\/G syndrome. Bioessays. 2003, 25: 356-366. 10.1002\/bies.10256","journal-title":"Bioessays"},{"key":"1357_CR8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nm.3049","volume":"19","author":"A Collison","year":"2013","unstructured":"Collison A, Hatchwell L, Verrills N, Wark PA, de Siqueira AP, Tooze M, Carpenter H, Don AS, Morris JC, Zimmermann N, Bartlett NW, Rothenberg ME, Johnston SL, Foster PS, Mattes J: The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat Med. 2013, 19: 232-237. 10.1038\/nm.3049","journal-title":"Nat Med"},{"key":"1357_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11010-009-0267-2","volume":"336","author":"S Prasad","year":"2010","unstructured":"Prasad S, Ravindran J, Aggarwal BB: NF-kappaB and cancer: how intimate is this relationship. Mol Cell Biochem. 2010, 336: 25-37. 10.1007\/s11010-009-0267-2","journal-title":"Mol Cell Biochem"},{"issue":"Supp","key":"1357_CR10","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1097\/01.blo.0000093048.96273.aa","volume":"415","author":"VB Andela","year":"2003","unstructured":"Andela VB, Gordon AH, Zotalis G, Rosier RN, Goater JJ, Lewis GD, Schwarz EM, Puzas JE, O\u2019Keefe RJ: NFkappaB: a pivotal transcription factor in prostate cancer metastasis to bone. Clin Orthop Relat Res. 2003, 415 (Supp): S75-S85.","journal-title":"Clin Orthop Relat Res"},{"key":"1357_CR11","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1074\/jbc.M209527200","volume":"278","author":"AV Pandey","year":"2003","unstructured":"Pandey AV, Mellon SH, Miller WL: Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17. J Biol Chem. 2003, 278: 2837-2844. 10.1074\/jbc.M209527200","journal-title":"J Biol Chem"},{"key":"1357_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1464-410X.2011.10643.x","volume":"109","author":"DJ Lee","year":"2012","unstructured":"Lee DJ, Cha EK, Dubin JM, Beltran H, Chromecki TF, Fajkovic H, Scherr DS, Tagawa ST, Shariat SF: Novel therapeutics for the management of castration-resistant prostate cancer (CRPC). BJU Int. 2012, 109: 968-985. 10.1111\/j.1464-410X.2011.10643.x","journal-title":"BJU Int"},{"key":"1357_CR13","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.1158\/0008-5472.CAN-07-6174","volume":"68","author":"S Krauss","year":"2008","unstructured":"Krauss S, Foerster J, Schneider R, Schweiger S: Protein phosphatase 2A and rapamycin regulate the nuclear localization and activity of the transcription factor GLI3. Cancer Res. 2008, 68: 4658-4665. 10.1158\/0008-5472.CAN-07-6174","journal-title":"Cancer Res"},{"key":"1357_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/ejhg.2008.10","volume":"16","author":"FD Porter","year":"2008","unstructured":"Porter FD: Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet. 2008, 16: 535-541. 10.1038\/ejhg.2008.10","journal-title":"Eur J Hum Genet"},{"key":"1357_CR15","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1073\/pnas.1100131108","volume":"108","author":"E Liu","year":"2011","unstructured":"Liu E, Knutzen CA, Krauss S, Schweiger S, Chiang GG: Control of mTORC1 signaling by the Opitz syndrome protein MID1. Proc Natl Acad Sci U S A. 2011, 108: 8680-8685. 10.1073\/pnas.1100131108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1357_CR16","doi-asserted-by":"publisher","first-page":"39945","DOI":"10.1074\/jbc.M111.224451","volume":"286","author":"B Aranda-Orgilles","year":"2011","unstructured":"Aranda-Orgilles B, Rutschow D, Zeller R, Karagiannidis AI, Koehler A, Chen C, Wilson T, Krause S, Roepcke S, Lilley D, Schneider R, Schweiger S: The PP2a-Specific Ubiquitin Ligase Mid1 is a Sequence-Dependent Regulator of Translation Efficiency Controlling 3-Phosphoinositide Dependent Protein Kinase-1 (PDPK-1). J Biol Chem. 2011, 286: 39945-39957. 10.1074\/jbc.M111.224451","journal-title":"J Biol Chem"},{"key":"1357_CR17","doi-asserted-by":"publisher","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-09-0820","volume":"69","author":"M Maurer","year":"2009","unstructured":"Maurer M, Su T, Saal LH, Koujak S, Hopkins BD, Barkley CR, Wu J, Nandula S, Dutta B, Xie Y, Chin YR, Kim DI, Ferris JS, Gruvberger-Saal SK, Laakso M, Wang X, Memeo L, Rojtman A, Matos T, Yu JS, Cordon-Cardo C, Isola J, Terry MB, Toker A, Mills GB, Zhao JJ, Murty VV, Hibshoosh H, Parsons R: 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma. Cancer Res. 2009, 69: 6299-6306. 10.1158\/0008-5472.CAN-09-0820","journal-title":"Cancer Res"},{"key":"1357_CR18","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1038\/ncomms2514","volume":"4","author":"S Krauss","year":"2013","unstructured":"Krauss S, Griesche N, Jastrzebska E, Chen C, Rutschow D, Achmuller C, Dorn S, Boesch SM, Lalowski M, Wanker E, Schneider R, Schweiger S: Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex. Nat Commun. 2013, 4: 1511-","journal-title":"Nat Commun"},{"key":"1357_CR19","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.2174\/092986711796011238","volume":"18","author":"C Raimondi","year":"2011","unstructured":"Raimondi C, Falasca M: Targeting PDK1 in cancer. Curr Med Chem. 2011, 18: 2763-2769. 10.2174\/092986711796011238","journal-title":"Curr Med Chem"},{"key":"1357_CR20","doi-asserted-by":"publisher","first-page":"e3507","DOI":"10.1371\/journal.pone.0003507","volume":"3","author":"B Aranda-Orgill\u00e9s","year":"2008","unstructured":"Aranda-Orgill\u00e9s B, Aigner J, Kunath M, Lurz R, Schneider R, Schweiger S: Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A. PLoS One. 2008, 3: e3507- 10.1371\/journal.pone.0003507","journal-title":"PLoS One"},{"key":"1357_CR21","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/nar\/gkq1323","volume":"39","author":"M de Mezer","year":"2011","unstructured":"de Mezer M, Wojciechowska M, Napierala M, Sobczak K, Krzyzosiak WJ: Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res. 2011, 39: 3852-3863. 10.1093\/nar\/gkq1323","journal-title":"Nucleic Acids Res"},{"key":"1357_CR22","first-page":"18","volume":"6","author":"N Baculescu","year":"2013","unstructured":"Baculescu N: The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS. J Med Life. 2013, 6: 18-25.","journal-title":"J Med Life"},{"key":"1357_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/JME-06-0072","volume":"39","author":"FF Brockschmidt","year":"2007","unstructured":"Brockschmidt FF, Nothen MM, Hillmer AM: The two most common alleles of the coding GGN repeat in the androgen receptor gene cause differences in protein function. J Mol Endocrinol. 2007, 39: 1-8. 10.1677\/JME-06-0072","journal-title":"J Mol Endocrinol"},{"key":"1357_CR24","first-page":"1527","volume":"10","author":"CS Choong","year":"1996","unstructured":"Choong CS, Kemppainen JA, Zhou ZX, Wilson EM: Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol. 1996, 10: 1527-1535.","journal-title":"Mol Endocrinol"},{"key":"1357_CR25","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/pros.21187","volume":"70","author":"MJ Pfeiffer","year":"2010","unstructured":"Pfeiffer MJ, Mulders PF, Schalken JA: An in vitro model for preclinical testing of endocrine therapy combinations for prostate cancer. Prostate. 2010, 70: 1524-1532. 10.1002\/pros.21187","journal-title":"Prostate"},{"key":"1357_CR26","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/onc.2011.401","volume":"31","author":"A Urbanucci","year":"2012","unstructured":"Urbanucci A, Sahu B, Seppala J, Larjo A, Latonen LM, Waltering KK, Tammela TL, Vessella RL, Lahdesmaki H, Janne OA, Visakorpi T: Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer. Oncogene. 2012, 31: 2153-2163. 10.1038\/onc.2011.401","journal-title":"Oncogene"},{"key":"1357_CR27","doi-asserted-by":"publisher","first-page":"27183","DOI":"10.1074\/jbc.M202883200","volume":"277","author":"BB Yeap","year":"2002","unstructured":"Yeap BB, Voon DC, Vivian JP, McCulloch RK, Thomson AM, Giles KM, Czyzyk-Krzeska MF, Furneaux H, Wilce MC, Wilce JA, Leedman PJ: Novel binding of HuR and poly(C)-binding protein to a conserved UC-rich motif within the 3\u2032-untranslated region of the androgen receptor messenger RNA. J Biol Chem. 2002, 277: 27183-27192. 10.1074\/jbc.M202883200","journal-title":"J Biol Chem"},{"key":"1357_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/15216540216033","volume":"54","author":"JA Wilce","year":"2002","unstructured":"Wilce JA, Leedman PJ, Wilce MC: RNA-binding proteins that target the androgen receptor mRNA. IUBMB Life. 2002, 54: 345-349. 10.1080\/15216540216033","journal-title":"IUBMB Life"},{"key":"1357_CR29","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/en.2009-1264","volume":"151","author":"B Cloke","year":"2011","unstructured":"Cloke B, Shah K, Kaneda H, Lavery S, Trew G, Fusi L, Higham J, Dina RE, Ghaem-Maghami S, Ellis P, Brosens JJ, Christian M: The poly(c)-binding protein-1 regulates expression of the androgen receptor. Endocrinology. 2011, 151: 3954-3964.","journal-title":"Endocrinology"},{"key":"1357_CR30","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/bies.20051","volume":"26","author":"BB Yeap","year":"2004","unstructured":"Yeap BB, Wilce JA, Leedman PJ: The androgen receptor mRNA. Bioessays. 2004, 26: 672-682. 10.1002\/bies.20051","journal-title":"Bioessays"},{"key":"1357_CR31","doi-asserted-by":"publisher","first-page":"14833","DOI":"10.3390\/ijms140714833","volume":"14","author":"T van der Steen","year":"2013","unstructured":"van der Steen T, Tindall DJ, Huang H: Posttranslational modification of the androgen receptor in prostate cancer. Int J Mol Sci. 2013, 14: 14833-14859. 10.3390\/ijms140714833","journal-title":"Int J Mol Sci"},{"key":"1357_CR32","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0039-128X(96)00086-4","volume":"61","author":"JL Dai","year":"1996","unstructured":"Dai JL, Maiorino CA, Gkonos PJ, Burnstein KL: Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells. Steroids. 1996, 61: 531-539. 10.1016\/S0039-128X(96)00086-4","journal-title":"Steroids"},{"key":"1357_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0303-7207(96)03939-1","volume":"124","author":"GR Mora","year":"1996","unstructured":"Mora GR, Mahesh VB: Autoregulation of androgen receptor in rat ventral prostate: involvement of c-fos as a negative regulator. Mol Cell Endocrinol. 1996, 124: 111-120. 10.1016\/S0303-7207(96)03939-1","journal-title":"Mol Cell Endocrinol"},{"key":"1357_CR34","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1210\/mend.13.11.0369","volume":"13","author":"JM Grad","year":"1999","unstructured":"Grad JM, Dai JL, Wu S, Burnstein KL: Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA. Mol Endocrinol. 1999, 13: 1896-1911. 10.1210\/mend.13.11.0369","journal-title":"Mol Endocrinol"},{"key":"1357_CR35","doi-asserted-by":"publisher","first-page":"28988","DOI":"10.1074\/jbc.M710528200","volume":"283","author":"H Li","year":"2008","unstructured":"Li H, Xu LL, Masuda K, Raymundo E, McLeod DG, Dobi A, Srivastava S: A feedback loop between the androgen receptor and a NEDD4-binding protein, PMEPA1, in prostate cancer cells. J Biol Chem. 2008, 283: 28988-28995. 10.1074\/jbc.M710528200","journal-title":"J Biol Chem"},{"key":"1357_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ccr.2011.09.001","volume":"20","author":"C Cai","year":"2010","unstructured":"Cai C, He HH, Chen S, Coleman I, Wang H, Fang Z, Nelson PS, Liu XS, Brown M, Balk SP: Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. Cancer Cell. 2010, 20: 457-471.","journal-title":"Cancer Cell"},{"key":"1357_CR37","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2007.05.041","volume":"27","author":"Q Wang","year":"2007","unstructured":"Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M: A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell. 2007, 27: 380-392. 10.1016\/j.molcel.2007.05.041","journal-title":"Mol Cell"},{"key":"1357_CR38","doi-asserted-by":"publisher","first-page":"5351","DOI":"10.1093\/nar\/gkq278","volume":"38","author":"M Lanzino","year":"2010","unstructured":"Lanzino M, Sisci D, Morelli C, Garofalo C, Catalano S, Casaburi I, Capparelli C, Giordano C, Giordano F, Maggiolini M, Ando S: Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells\u2013identification of a novel androgen response element. Nucleic Acids Res. 2010, 38: 5351-5365. 10.1093\/nar\/gkq278","journal-title":"Nucleic Acids Res"},{"key":"1357_CR39","doi-asserted-by":"publisher","first-page":"304292","DOI":"10.1155\/2012\/304292","volume":"2012","author":"G Garruti","year":"2012","unstructured":"Garruti G, Wang HH, Bonfrate L, de Bari O, Wang DQ, Portincasa P: A pleiotropic role for the orphan nuclear receptor small heterodimer partner in lipid homeostasis and metabolic pathways. J Lipids. 2012, 2012: 304292-","journal-title":"J Lipids"},{"key":"1357_CR40","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.juro.2006.06.066","volume":"176","author":"T Nishiyama","year":"2006","unstructured":"Nishiyama T, Ikarashi T, Hashimoto Y, Suzuki K, Takahashi K: Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score. J Urol. 2006, 176: 1387-1391. 10.1016\/j.juro.2006.06.066","journal-title":"J Urol"},{"key":"1357_CR41","first-page":"3615","volume":"31","author":"C Kratzik","year":"2011","unstructured":"Kratzik C, Womastek I, Bieglmayer C, Schatzl G, Lackner J, Freibauer C, Lunglmayr G: Lower serum total testosterone is associated with lymph node metastases in a radical prostatectomy cohort study. Anticancer Res. 2011, 31: 3615-3618.","journal-title":"Anticancer Res"},{"key":"1357_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/pros.1046","volume":"47","author":"G Schatzl","year":"2001","unstructured":"Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A, Marberger M: High-grade prostate cancer is associated with low serum testosterone levels. Prostate. 2001, 47: 52-58. 10.1002\/pros.1046","journal-title":"Prostate"},{"key":"1357_CR43","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/acel.12075","volume":"12","author":"O Moiseeva","year":"2013","unstructured":"Moiseeva O, Deschenes-Simard X, St-Germain E, Igelmann S, Huot G, Cadar AE, Bourdeau V, Pollak MN, Ferbeyre G: Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK\/NF-kappaB activation. Aging Cell. 2013, 12: 489-498. 10.1111\/acel.12075","journal-title":"Aging Cell"},{"key":"1357_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000341837","volume":"40","author":"R Pasquali","year":"2013","unstructured":"Pasquali R, Gambineri A: Insulin sensitizers in polycystic ovary syndrome. Front Horm Res. 2013, 40: 83-102.","journal-title":"Front Horm Res"},{"key":"1357_CR45","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1002\/pros.20469","volume":"66","author":"K Jennbacken","year":"2006","unstructured":"Jennbacken K, Gustavsson H, Welen K, Vallbo C, Damber JE: Prostate cancer progression into androgen independency is associated with alterations in cell adhesion and invasivity. Prostate. 2006, 66: 1631-1640. 10.1002\/pros.20469","journal-title":"Prostate"},{"key":"1357_CR46","doi-asserted-by":"publisher","first-page":"21830","DOI":"10.1073\/pnas.0912793107","volume":"107","author":"E Kickstein","year":"2010","unstructured":"Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, Kohler A, Glossmann H, Schneider R, Sutherland C, Schweiger S: Biguanide metformin acts on tau phosphorylation via mTOR\/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci U S A. 2010, 107: 21830-21835. 10.1073\/pnas.0912793107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1357_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1471-2407-14-52","volume":"14","author":"U Demir","year":"2014","unstructured":"Demir U, Koehler A, Schneider R, Schweiger S, Klocker H: Metformin anti-tumor effect via disruption of the MID1 translational regulator complex and AR downregulation in prostate cancer cells. BMC Cancer. 2014, 14: 52- 10.1186\/1471-2407-14-52","journal-title":"BMC Cancer"},{"key":"1357_CR48","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1158\/0008-5472.CAN-11-0532","volume":"71","author":"C Cai","year":"2011","unstructured":"Cai C, Chen S, Ng P, Bubley GJ, Nelson PS, Mostaghel EA, Marck B, Matsumoto AM, Simon NI, Wang H, Balk SP: Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors. Cancer Res. 2011, 71: 6503-6513. 10.1158\/0008-5472.CAN-11-0532","journal-title":"Cancer Res"},{"key":"1357_CR49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/path.2668","volume":"220","author":"JM Hao","year":"2010","unstructured":"Hao JM, Chen JZ, Sui HM, Si-Ma XQ, Li GQ, Liu C, Li JL, Ding YQ, Li JM: A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer. J Pathol. 2010, 220: 475-489.","journal-title":"J Pathol"},{"key":"1357_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1440-1827.2011.02644.x","volume":"61","author":"S Sakashita","year":"2011","unstructured":"Sakashita S, Li D, Nashima N, Minami Y, Furuya S, Morishita Y, Tachibana K, Sato Y, Noguchi M: Overexpression of immunoglobulin (CD79a) binding protein1 (IGBP-1) in small lung adenocarcinomas and its clinicopathological significance. Pathol Int. 2011, 61: 130-137. 10.1111\/j.1440-1827.2011.02644.x","journal-title":"Pathol Int"},{"key":"1357_CR51","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1158\/1535-7163.MCT-10-1096","volume":"10","author":"A Bhardwaj","year":"2011","unstructured":"Bhardwaj A, Singh S, Srivastava SK, Honkanen RE, Reed E, Singh AP: Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications. Mol Cancer Ther. 2011, 10: 720-731. 10.1158\/1535-7163.MCT-10-1096","journal-title":"Mol Cancer Ther"},{"key":"1357_CR52","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ajhg.2010.11.001","volume":"87","author":"A Kloss-Brandstatter","year":"2010","unstructured":"Kloss-Brandstatter A, Schafer G, Erhart G, Huttenhofer A, Coassin S, Seifarth C, Summerer M, Bektic J, Klocker H, Kronenberg F: Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients. Am J Hum Genet. 2010, 87: 802-812. 10.1016\/j.ajhg.2010.11.001","journal-title":"Am J Hum Genet"},{"key":"1357_CR53","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/febs.12118","volume":"280","author":"H Bu","year":"2013","unstructured":"Bu H, Schweiger MR, Manke T, Wunderlich A, Timmermann B, Kerick M, Pasqualini L, Shehu E, Fuchsberger C, Cato AC, Klocker H: Anterior gradient 2 and 3\u2013two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells. FEBS J. 2013, 280: 1249-1266. 10.1111\/febs.12118","journal-title":"FEBS J"},{"key":"1357_CR54","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead B, Trapnell C, Pop M, Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009, 10: R25- 10.1186\/gb-2009-10-3-r25","journal-title":"Genome Biol"},{"key":"1357_CR55","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, Nusbaum C, Myers RM, Brown M, Li W, Liu XS: Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008, 9: R137- 10.1186\/gb-2008-9-9-r137","journal-title":"Genome Biol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T04:37:57Z","timestamp":1630557477000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,9]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1357"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-146","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,9]]},"assertion":[{"value":"14 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"146"}}